Public Workshop: Evaluating Benefit-Risk in Robotic Medical Devices with Autonomous or Remote Teleoperation Capabilities
The FDA will host a hybrid, two-day public workshop focused on autonomous and remote teleoperated robotic medical devices.
The FDA will host a hybrid, two-day public workshop focused on autonomous and remote teleoperated robotic medical devices.